Papers

2

Total Citations

15

H-Index

2

About

Dr. Ali Alenazy is a pioneering cardiac surgeon whose work is redefining the boundaries of robotic cardiothoracic surgery. His primary research focuses on the development and clinical implementation of minimally invasive robotic techniques for complex cardiac procedures, with a particular emphasis on valve replacement and transplantation. Dr. Alenazy’s most significant contribution is his leadership in the world’s first “totally robotic orthotopic heart transplant,” a groundbreaking achievement published in 2025 that has already garnered 13 citations, signaling its immediate impact on the field. This work demonstrates the feasibility of applying robotic precision to the most demanding of cardiac operations. Additionally, his research on robotic aortic valve replacement (RAVR) has been instrumental in establishing its reproducibility and safety in the Middle East. By assessing short- and mid-term outcomes for patients undergoing RAVR from 2022 to 2024, his studies provide crucial follow-up data that support the broader adoption of this evolving technique. Through these landmark innovations, Dr. Alenazy is not only advancing surgical practice but also setting a new standard for what is achievable in robotic cardiac surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
“First-in-human” totally robotic orthotopic heart transplant
13 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: King Faisal Specialist Hospital & Research Centre

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago